Cargando…
Metabolic signatures of insulin resistance in non-diabetic individuals
BACKGROUND: Insulin resistance (IR) evolved from excessive energy intake and poor energy expenditure, affecting the patient's quality of life. Amino acid and acylcarnitine metabolomic profiles have identified consistent patterns associated with metabolic disease and insulin sensitivity. Here, w...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404631/ https://www.ncbi.nlm.nih.gov/pubmed/36002887 http://dx.doi.org/10.1186/s12902-022-01130-3 |
_version_ | 1784773683218219008 |
---|---|
author | Arjmand, Babak Ebrahimi Fana, Saeed Ghasemi, Erfan Kazemi, Ameneh Ghodssi-Ghassemabadi, Robabeh Dehghanbanadaki, Hojat Najjar, Niloufar Kakaii, Ardeshir Forouzanfar, Katayoon Nasli-Esfahani, Ensieh Farzadfar, Farshad Larijani, Bagher Razi, Farideh |
author_facet | Arjmand, Babak Ebrahimi Fana, Saeed Ghasemi, Erfan Kazemi, Ameneh Ghodssi-Ghassemabadi, Robabeh Dehghanbanadaki, Hojat Najjar, Niloufar Kakaii, Ardeshir Forouzanfar, Katayoon Nasli-Esfahani, Ensieh Farzadfar, Farshad Larijani, Bagher Razi, Farideh |
author_sort | Arjmand, Babak |
collection | PubMed |
description | BACKGROUND: Insulin resistance (IR) evolved from excessive energy intake and poor energy expenditure, affecting the patient's quality of life. Amino acid and acylcarnitine metabolomic profiles have identified consistent patterns associated with metabolic disease and insulin sensitivity. Here, we have measured a wide array of metabolites (30 acylcarnitines and 20 amino acids) with the MS/MS and investigated the association of metabolic profile with insulin resistance. METHODS: The study population (n = 403) was randomly chosen from non-diabetic participants of the Surveillance of Risk Factors of NCDs in Iran Study (STEPS 2016). STEPS 2016 is a population-based cross-sectional study conducted periodically on adults aged 18–75 years in 30 provinces of Iran. Participants were divided into two groups according to the optimal cut-off point determined by the Youden index of HOMA-IR for the diagnosis of metabolic syndrome. Associations were investigated using regression models adjusted for age, sex, and body mass index (BMI). RESULTS: People with high IR were significantly younger, and had higher education level, BMI, waist circumference, FPG, HbA1c, ALT, triglyceride, cholesterol, non-HDL cholesterol, uric acid, and a lower HDL-C level. We observed a strong positive association of serum BCAA (valine and leucine), AAA (tyrosine, tryptophan, and phenylalanine), alanine, and C0 (free carnitine) with IR (HOMA-IR); while C18:1 (oleoyl L-carnitine) was inversely correlated with IR. CONCLUSIONS: In the present study, we identified specific metabolites linked to HOMA-IR that improved IR prediction. In summary, our study adds more evidence that a particular metabolomic profile perturbation is associated with metabolic disease and reemphasizes the significance of understanding the biochemistry and physiology which lead to these associations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-022-01130-3. |
format | Online Article Text |
id | pubmed-9404631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94046312022-08-26 Metabolic signatures of insulin resistance in non-diabetic individuals Arjmand, Babak Ebrahimi Fana, Saeed Ghasemi, Erfan Kazemi, Ameneh Ghodssi-Ghassemabadi, Robabeh Dehghanbanadaki, Hojat Najjar, Niloufar Kakaii, Ardeshir Forouzanfar, Katayoon Nasli-Esfahani, Ensieh Farzadfar, Farshad Larijani, Bagher Razi, Farideh BMC Endocr Disord Research BACKGROUND: Insulin resistance (IR) evolved from excessive energy intake and poor energy expenditure, affecting the patient's quality of life. Amino acid and acylcarnitine metabolomic profiles have identified consistent patterns associated with metabolic disease and insulin sensitivity. Here, we have measured a wide array of metabolites (30 acylcarnitines and 20 amino acids) with the MS/MS and investigated the association of metabolic profile with insulin resistance. METHODS: The study population (n = 403) was randomly chosen from non-diabetic participants of the Surveillance of Risk Factors of NCDs in Iran Study (STEPS 2016). STEPS 2016 is a population-based cross-sectional study conducted periodically on adults aged 18–75 years in 30 provinces of Iran. Participants were divided into two groups according to the optimal cut-off point determined by the Youden index of HOMA-IR for the diagnosis of metabolic syndrome. Associations were investigated using regression models adjusted for age, sex, and body mass index (BMI). RESULTS: People with high IR were significantly younger, and had higher education level, BMI, waist circumference, FPG, HbA1c, ALT, triglyceride, cholesterol, non-HDL cholesterol, uric acid, and a lower HDL-C level. We observed a strong positive association of serum BCAA (valine and leucine), AAA (tyrosine, tryptophan, and phenylalanine), alanine, and C0 (free carnitine) with IR (HOMA-IR); while C18:1 (oleoyl L-carnitine) was inversely correlated with IR. CONCLUSIONS: In the present study, we identified specific metabolites linked to HOMA-IR that improved IR prediction. In summary, our study adds more evidence that a particular metabolomic profile perturbation is associated with metabolic disease and reemphasizes the significance of understanding the biochemistry and physiology which lead to these associations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-022-01130-3. BioMed Central 2022-08-24 /pmc/articles/PMC9404631/ /pubmed/36002887 http://dx.doi.org/10.1186/s12902-022-01130-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Arjmand, Babak Ebrahimi Fana, Saeed Ghasemi, Erfan Kazemi, Ameneh Ghodssi-Ghassemabadi, Robabeh Dehghanbanadaki, Hojat Najjar, Niloufar Kakaii, Ardeshir Forouzanfar, Katayoon Nasli-Esfahani, Ensieh Farzadfar, Farshad Larijani, Bagher Razi, Farideh Metabolic signatures of insulin resistance in non-diabetic individuals |
title | Metabolic signatures of insulin resistance in non-diabetic individuals |
title_full | Metabolic signatures of insulin resistance in non-diabetic individuals |
title_fullStr | Metabolic signatures of insulin resistance in non-diabetic individuals |
title_full_unstemmed | Metabolic signatures of insulin resistance in non-diabetic individuals |
title_short | Metabolic signatures of insulin resistance in non-diabetic individuals |
title_sort | metabolic signatures of insulin resistance in non-diabetic individuals |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404631/ https://www.ncbi.nlm.nih.gov/pubmed/36002887 http://dx.doi.org/10.1186/s12902-022-01130-3 |
work_keys_str_mv | AT arjmandbabak metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT ebrahimifanasaeed metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT ghasemierfan metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT kazemiameneh metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT ghodssighassemabadirobabeh metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT dehghanbanadakihojat metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT najjarniloufar metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT kakaiiardeshir metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT forouzanfarkatayoon metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT nasliesfahaniensieh metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT farzadfarfarshad metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT larijanibagher metabolicsignaturesofinsulinresistanceinnondiabeticindividuals AT razifarideh metabolicsignaturesofinsulinresistanceinnondiabeticindividuals |